Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

National Institute of Neurological Disorders and Stroke (NINDS) · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
covidlong-covid
post-acute covid-19 syndrome, pasc, long covid, covid, covid-19, postacute sequelae of covid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833926
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.